Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant Chemotherapy
Bernhard Kiss(University of Bern), Roland Seiler(University of British Columbia), James W. Douglas(University of North Carolina at Charlotte), Elai Davicioni(Coherus BioSciences (United States)), Matthew Sommerlad, Beatrix Palmer-Aronsten(Genome British Columbia), Ewan A. Gibb(BC Cancer Agency), George N. Thalmann(University Hospital of Bern), Michiel S. van der Heijden(Zorginstituut Nederland), Lucia L.C. Lam(Genome British Columbia), Ellen C. Zwarthoff(Erasmus MC), Jordan Kardos(University of North Carolina at Chapel Hill), Nicholas Erho(Genome British Columbia), Seth P. Lerner(Baylor College of Medicine), Peter C. Black(University of British Columbia), Kim E. van Kessel(Erasmus MC), David J. McConkey(Johns Hopkins University), Natalie Q. Wang(Genome British Columbia), Scott North, Tilman Todenhöfer(University of British Columbia), Gottfrid Sjödahl(Lund University), Elisabeth E. Fransen van de Putte(The Netherlands Cancer Institute), Simon J. Crabb(University of Southampton), Joost L. Boormans(Erasmus MC), Jonathan L. Wright(Seattle University), Marc Dall’Era(University of California, Davis), William Y. Kim(University of North Carolina at Chapel Hill), Voleak Choeurng, Woonyoung Choi(The University of Texas MD Anderson Cancer Center), H.A.D.M. Ashab(Genome British Columbia), Brian Winters(University of Washington), Katherine A. Hoadley(University of North Carolina at Chapel Hill), Bas W.G. van Rhijn(The Netherlands Cancer Institute), Christine Buerki(Genome British Columbia)
Carolina Digital Repository (University of North Carolina at Chapel Hill)
April 16, 2020
Cited by 0